Latest News Archive
Please select Category, Year, and then Month to display items
23 November 2022
|
Story André Damons
Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.
The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.
The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.
Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.

Justin J. Kennedy leads new Programme in Personal Excellence
2012-05-08
|
Justin J. Kennedy
Photo: Leatitia Pienaar
8 May 2012
|
Justin J. Kennedy has been appointed as the Manager of the new Programme in Personal Excellence. The programme is hosted in the Centre for Business Dynamics, the commercial unit of the Business School.
He studied at Rhodes University and the University of the Western Cape (UWC) and his research has been published in various health-related publications. His D.Psych. at the University of California migrated into a Ph.D. with research partner DiscoveryHealth.
While in New York, he was part of the research laboratory Helicor that developed the world’s first hand-held medical device for measuring heart-rate variability of the peripheral nervous system. This device forms part of the programmes offered to control stress and improve cognitive performance as per clinical trials at the UCT Department of Human Biology. This programme evolved into developing the M.Sc. course work on occupational stress and Ph.D. student supervision.
The programme will launch during the university's Beneficiary Programme for Academic Heads of Department, and will focus on the neuro-economics of stress resilience.
Justin’s most recent research is peer review for an international leadership journal where he has presented evidence on how people can improve their cognitive performance and working memory by building functional stress resilience. The overall aim of the programme is to not only reduce stress, but to improve ability to be excellent at work. Clinical results have shown it is beneficial for performance anxiety, insomnia, migraine, hypertension control and improved ability at cognitive tasks. The aim of his work is to ensure that simple and practical skills provide academics, students and corporate participants with enduring, functional techniques that are easily applied in their working lives.
The programme has three roles: to offer services that equip students and academics; consulting services to corporate clients, financial groups and private hospitals; and publication of results in peer-reviewed journals.
This initiative also envisages offering a postgraduate qualification and selected coaching qualifications. For more info about corporate interventions and programmes open to students and academics, please contact Ansie Barnard at barnardam@ufs.ac.za.